(hereinafter referred to as "NDT" or "we") for the sole purpose of providing relevant information. These terms and conditions were last updated on 1 March 2021 and are subject to change at any time. By using this website or downloading materials from this website, you agree to be bound by the terms and conditions set out in this notice. If you do not agree to these terms and conditions, please do not use this website or download materials from this website.
This website does not provide medical advice and most of the information provided on this website relates to NERVTEX products or services. Please understand that the information you read on this website is not a substitute for a relationship between you and a healthcare professional. NERVTEX does not provide treatment, medical services or related advice and you should not consider the information provided on this website as medical advice. If you require diagnosis or treatment, you should always speak to a healthcare professional.
Whilst NERVTEX endeavours to include up-to-date information about its products and services and other information on this website, NERVTEX does not warrant that the information on this website is accurate, complete, current or appropriate. You assume all responsibility and risk arising from your use of this website. The information on this website is provided "as is" and may include technical inaccuracies or typographical errors. NERVTEX reserves the right to make additions, deletions or modifications to the information on this website at any time without prior notice.
NERVTEX makes no representations or warranties that this website will be uninterrupted or error free. Any material downloaded or obtained through the use of this website is done at your own discretion and risk. NERVTEX shall not be liable for any damage to your computer system or loss of data that results from the download of such material.
NERVTEX makes no representations or warranties of any kind with respect to the information or content on this website. NERVTEX makes no representations or warranties of any kind, whether express or implied, statutory, contractual or otherwise, including but not limited to any warranties of merchantability, fitness for a particular purpose, title or non-infringement. in no event shall NERVTEX be liable for any damages whatsoever, including without limitation, direct, indirect, special (including lost profits), consequential or incidental damages arising out of or in connection with this website and/or the information or content on this website, whether or not NERVTEX is aware of the possibility of such damages.
NERVTEX is not responsible for and does not guarantee the accuracy, validity, currency or appropriateness of any information or content provided by third parties (including any links to third party websites). Unless otherwise stated on this website, NERVTEX has no ability to edit, review or otherwise control any third party content on this website. Accordingly, such information should not be relied upon as having been approved by NERVTEX.
This website may contain forward-looking statements that reflect NERVTEX's current expectations regarding future activities and business developments. Forward-looking statements are subject to risks and uncertainties. Actual developments or results may differ materially from those projected and will depend on a number of factors including, but not limited to, the success of ongoing research programmes, the results of pending or future clinical trials, the current level of commercialisation of products, the stability of commercial relationships and general economic conditions. Please note that although NERVTEX intends to update this website periodically, it is under no obligation to do so.
For the purposes of these terms and conditions, the information, documents and related graphics (collectively the "Information") published on this website shall be deemed to be the exclusive property of NDT Medical, except for Information provided by third parties under contract to NDT Medical and its subsidiaries and affiliates. You may not infringe such intellectual property rights and related rights in any way, including, without limitation, by removing or defacing any copyright or other proprietary notices contained in the services, products or information we make available through this site. You may e-mail, download or print copies of information obtained through this website for your personal, non-commercial use only. If you e-mail, download or print a copy of such information, you must retain all copyright and other notices contained in the information, including the copyright notice at the bottom of the page (if applicable).
You are hereby granted a non-exclusive, limited and revocable licence to establish a link to this website. We reserve the right to revoke this permission or the right to use a particular link at any time. If we revoke this permission, you agree to immediately remove and disable any and all links to the Site from you.
You agree not to create or provide links to this site in a manner that involves advertising or disguising an organization, product or service, or in any manner that is prohibited by or inconsistent with applicable law. You agree that such links will not appear in any medium that a reasonable person might consider to be obscene, defamatory, harassing, or to involve copyright infringement or otherwise. Under no circumstances may you "frame" this website or any of its contents or copy any part of this website onto a server that is not owned or operated by us.
Neuromedical and any person or company associated with NERVTEX are not responsible for the materials, information and opinions provided, posted or otherwise made available on this website. Reliance on such materials, information and opinions is at your own risk. NERVTEX shall not be liable for any injury or damage arising out of the use of this website or the content therein.
Notwithstanding the foregoing, if we or any of our third party suppliers or distributors are found liable for any loss or damage arising out of or in any way connected with the use of this website or its content, the liability of NERVTEX (Shenzhen) Co., Limited, any of its affiliates, and its officers, directors, employees, agents, parent company, suppliers (if any) for loss or The entire liability for loss or damage shall be limited to the amount of actual damages and shall not exceed RMB1,000. In some countries, the limit of liability may not be valid. However, in no event shall Condensed Motion Medical Technology (Shenzhen) Limited, its affiliates, its officers, directors, employees, agents, parent companies or suppliers be liable for any loss or damage other than the amount stated above. all other direct or indirect, special, incidental, consequential, exemplary or punitive damages arising out of the use of this site or the content are excluded, even if NERVTEX (shenzhen) Co.,Limited has been advised of the possibility of such damages.
Over the past century, Nobel Prizes have been awarded for important discoveries in neuroscience related to the encoding and storage of information in the brain. We now have a better understanding of the brain's conduction mechanisms; we also have a good understanding of the role of different neurons and how they respond in different functions. However, our understanding is only at the level of how nerve cells process information, and we still know very little about the complex network structure of the whole brain. Questions such as how information is processed in the brain, how different sensory perceptions, emotions and some higher cognitive functions - thinking, decision making and even consciousness - are achieved, and how nerve cells are made to respond to different physical and chemical stimuli in specific situations, remain unsatisfactorily answered.
Over the past 100 years, imaging departments have had X-ray machines and magnetic resonance imaging, laboratory departments have had mass spectrometers and DNA fluorescent probes, and pathology departments have had electronic medical records and digital pathology, but none of these have helped neurologists and psychiatrists working with psychiatric and neurodegenerative brain disorders to reach an objective, accurate, convenient and well-documented conclusion in clinical care and outcome assessment.
The most critical issue in brain disease research is that we still do not understand the mechanisms of brain dysfunction caused by psychiatric and neurodegenerative disorders.
Despite tremendous advances in neuroscience in recent decades, we are still unable to fully unravel the relationship between the spatio-temporal activity patterns of interwoven neural networks and human behaviour, cognition, emotion and other mental states. Deciphering and promoting the function and health of the brain, the body's most mysterious organ, will have major implications for science, medicine and society.
Cognitive neuroscience based on brain imaging can elucidate the underlying mechanisms of cognitive dysfunction and provide a biological framework for discovering precise biomarkers of mindfulness disorders. At the same time, recent advances in brain-like research and artificial intelligence are providing important tools for understanding the biological brain and vice versa. The development of brain-inspired computing, brain simulations and intelligent machines is therefore receiving considerable attention in EU and Chinese brain programmes.
So can computer science help us with our 'physical' and 'mental' suffering?
The answer is YES
We launched NERVTEX to create solutions that understand the importance of human behaviour.
While computers cannot directly determine the meaning of behaviour, they can help us to record, identify, label, generalise and summarise the associations between different behaviours and disease. Conversely, in a computer-generated virtual environment, the human brain exhibits the same judgement and behavioural characteristics as in the real world, and provides timely feedback on scenarios that can be artificially adapted. Artificial intelligence and virtual reality are the most typical applications of this theory.
We believe that the ultimate solution for brain health is a combination of digital technology-driven medical devices and personalised medicine solutions, and that NERVTEX will focus on the innovation of "digital technology-driven standalone software-based medical devices", i.e. "digital therapeutics".
Starting from the principle of firstness, we try to think and ask the question, what is the objective expression of human physical and mental suffering?
Our answer is Behavior.
Why can't we use the physical and biochemical means at our disposal to solve our physical and mental problems?
With approximately 3 million people worldwide living with Parkinson's disease, 23 million with schizophrenia, 50 million with dementia, 140 million with obsessive-compulsive disorder, 200 million with stroke and 300 million with at least one of anxiety and depression, brain health problems represented by mental and neurological disorders have become the leading cause of the global burden of disease.
Difficulties in accurate assessment, lack of precise interventions and difficulties in patient management are some of the main reasons why mental and neurological disorders are 'invisible'. Due to our lack of understanding of the brain itself and its pathogenesis, clinical diagnosis and assessment of brain disorders can only be made with imaging tests such as CT and MRI when there is significant structural brain damage, but for functional brain disorders such as neurodegenerative and psychiatric disorders, there are still no objective indicators or tools to comprehensively assess or quantify the disease process. In the treatment of psychiatric and neurodegenerative brain disorders, the uncertainty of treatment response, the need to personalise treatment protocols, to accurately preserve brain function and to manage the prognosis of treatment protocols all require better assessment and treatment tools that are easy to use, objective and sensitive.
Behavioural change, the most basic phenotypic feature of psychiatric and neurodegenerative brain disorders, remains the central mainstream clinical assessment judgement in current practice. However, today's neurological and psychiatric consultation process does not adequately address the two most fundamental issues in behavioural assessment.
1. Is the basis for assessing behaviour change clean and consistent for each assessor?
2. Is disease diagnosis based on behaviour change sufficient to distinguish the effects of disease interventions?
In fact, when it comes to these two things, the difference in medical judgement between doctors is not as great as it was a hundred years ago, and neither is complete.
If these two issues can be addressed, we will be able to greatly improve the prevention, early screening and diagnosis of neuropsychiatric disorders, as well as the window of intervention to achieve better outcomes with lower doses and fewer side effects, while new drug development will have access to more objective and clearer gradient assessment tools, greatly expanding our treatment options.If these two issues can be addressed, we will be able to greatly improve the prevention, early screening and diagnosis of neuropsychiatric disorders, as well as the window of intervention to achieve better outcomes with lower doses and fewer side effects, while new drug development will have access to more objective and clearer gradient assessment tools, greatly expanding our treatment options.
Unfortunately, we are not yet able to address these issues well in clinical practice and we need standardised and objective tools for diagnosis and treatment.Unfortunately, we are not yet able to address these issues well in clinical practice and we need standardised and objective tools for diagnosis and treatment.
Combining new technologies such as artificial intelligence and virtual reality, a range of digital diagnostic and treatment tools for movement, mood and cognitive disorders will be established, with behavioural assessment and intervention at the core, supported by evidence-based medicine and clinical practice.
NERVTEX is committed to addressing the neuropsychiatric challenges facing today's healthcare system, with a focus on the key areas of motor dysfunction, cognitive memory disorders, emotional psychological disorders and behavioural developmental disorders. We listen to the clinical needs of patients and clinicians and translate new technologies such as artificial intelligence, virtual reality and digital interaction into innovative medical practices that further improve healthcare. At nervtex, we use technology to illuminate new journeys for patients and create a new experience of healthy living.